CClinicalTrials.gg
CompletedNCT04677348Updated Mar 23, 2022

Comparison of PENG Block and FICB in Hip Fracture Patients

An interventional study of Pericapsular nerve group (PENG) block and Fascia iliaca compartment block (FICB) in Hip Fractures and Regional Anesthesia, sponsored by Asan Medical Center. Completed at 1 site in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2022-03-23.

Sponsored by Asan Medical Center · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

Fascia iliaca compartment block (FICB) has been considered the block of choice for patients with hip fracture. However, pericapsular nerve group (PENG) block, one of the relatively newly-developed blocks, could be also used for analgesia in patients with hip fracture. Since PENG block could block the accessory obturator nerve, PENG block might have greater analgesic effects compared to FICB theoretically. However, the comparison of these two blocks in patients with hip fracture has not performed in clinical setting. Thus, we aimed to compare the analgesic effect of PENG block and FICB.

02

Conditions studied

  • Hip Fractures
  • Regional Anesthesia

Keywords

  • pericapsular nerve group block
  • fascia iliaca compartment block
  • hip fracture
  • regional anesthesia
  • dynamic pain
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's enrollment of 80 is above the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Asan Medical Center is the lead sponsor of 562 studies on the registry; 71 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ASA PS 1-4
  • age: ≥19
  • baseline pain score (associated with hip fracture): ≥4

Exclusion criteria

Exclusion Criteria:

  • patients who do not agree to participate in this study
  • patients with uncontrolled hypertension, hyperthyroidism, severe dementia
  • allergic to ropivacaine
  • contraindicated to spinal anesthesia due to coagulopathy, severe aortic stenosis/mitral stenosis, or active infection on lumbar region
  • patients who are considered ineligible with any other reason by investigators
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    PENG group

    pericapsular nerve group (PENG) block before surgery

    Procedure: Pericapsular nerve group (PENG) block

  • Active comparator
    FICB group

    suprainguinal fascia iliaca compartment block (FICB) before surgery

    Procedure: Fascia iliaca compartment block (FICB)

Interventions

  • ProcedurePericapsular nerve group (PENG) block

    ultrasound-guided PENG block with 0.3% ropivacaine 20cc

  • ProcedureFascia iliaca compartment block (FICB)

    ultrasound-guided suprainguinal FICB with 0.3% ropivacaine 30cc

06

What researchers measure

Primary outcomes

  1. Efficacy of each block (Pain score)

    We will assess the dynamic pain (pain during a movement) using NRS before and 20-30min after applying the assigned block. Then, we will calculate the change of NRS at the two time-points. NRS: Numerical rating scale (0, no pain; 10, the worst pain imaginable)

    Time frame: before surgery

Secondary outcomes

  1. change of blood pressure (systolic, diastolic, mean blood pressure)

    We will evaluate the blood pressure before and 20-30min after applying the assigned block. Then, we will calculate the change of blood pressure at the two time-points.

    Time frame: before surgery

  2. postoperative pain score

    resting and dynamic pain using NRS at postoperative 6, 24, 48hours NRS: Numerical rating scale (0, no pain; 10, the worst pain imaginable)

    Time frame: postoperative 6, 24, 48hours

  3. postoperative opioid consumption

    morphine-equivalent dose

    Time frame: postoperative 24, 48hours

  4. postoperative motor function

    motor function of quadriceps femoris grade5: normal power grade4: movement possible against some resistance grade3: movement against gravity but not resistance grade2: movement possible if gravity eliminated grade1: flicker of contraction possible grade0: complete paralysis

    Time frame: postoperative 6, 24, 48hours

  5. change of heart rate

    We will evaluate the heart rate before and 20-30 min after applying the assigned block. Then, we will calculate the change of heart rate at the two time-points.

    Time frame: before surgery

07

Study locations

1 site
  • Asan Medical Center
    Seoul, 05505, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04677348
Lead sponsor
Asan Medical Center
Responsible party
Hajung Kim (Clinical assistant professor, Asan Medical Center) — Principal investigator
First posted
Dec 21, 2020
Start date
Jan 21, 2021
Primary completion
Jan 26, 2022
Completion
Feb 11, 2022
Last update
Mar 23, 2022

Study contacts

Won Uk Koh, MD, PhD
principal investigator · Asan Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion